The UDP-glucuronyltransferase inducers, phenobarbital and pregnenolone-16α-carbonitrile, enhance thyroid-follicular cell apoptosis: association with TGF-β1 expression

Toxicology Letters

Volumn 106, Issue 2-3, 1999, Pages 143-150

  Kolaja, Kyle L ^a   Hood, Alan M ^a   Klaassen, Curtis D ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; TGF 1; Thyroid; UDP GT inducers

Indexed keywords

16ALPHA CYANOPREGNENOLONE; ENZYME INDUCING AGENT; GLUCURONOSYLTRANSFERASE; PHENOBARBITAL; PROPYLTHIOURACIL; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; THYROID FOLLICLE CELL;

ANIMALS; APOPTOSIS; ENZYME INDUCTION; GLUCURONOSYLTRANSFERASE; HYPERPLASIA; MALE; PHENOBARBITAL; PREGNENOLONE CARBONITRILE; RATS; RATS, SPRAGUE-DAWLEY; THYROID GLAND; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032993873     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00023-5     Document Type: Article

References (25)

1. Asmis L., Kaempf J., Von Gruenigen C., Kimura E., Wagner H., Studer H. Acquired and naturally occurring resistance of thyroid follicular cells to the growth inhibitory action of transforming growth factor-β1 (TGF-β1). J. Endocrinol. 149:1996;485-496.
2. Barter R.A., Klaassen C.D. Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats. Toxicol. Appl. Pharm. 128:1994;9-17.
3. Blaydes J., Wynford-Thomas D. Loss of responsiveness to transforming growth factor β (TGFβ) is tightly linked to tumorigenicity in a model of thyroid tumor progression. Int. J. Cancer. 65:1996;525-530.
4. Border W., Ruoslahti E. Transforming growth factor β in disease: the dark side of tissue repair. J. Clin. Invest. 90:1992;1-7.
5. Bursch W., Lauer B., Timmermann-Trosnier I., Barthel G., Schuppler J., Hermann R. Controlled death (apoptosis) of normal and preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogneesis. 5(1984):1984;453-458.
6. Bursch W., Taper H., Lauer B., Schulte-Hermann R. Quantitative histological and histochemical studies on the occurrence of and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch. B (Cell Pathol.). 50:1985;153-166.
7. Carneiro C., Alvarez C., Zalvide J., Vidal A., Dominquez F. TGF-beta1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth. Oncogene. 16:1998;1455-1465.
8. Froschl H., Rafferzeder M., Erlinger R., Gartner R. Identification of apoptosis in porcine thyroid follicular cells in vitro. J. Endocrinol. Invest. 1(Suppl. 17):1994;54.
9. Hill R.N., Erdreich L.S., Paytner O.E., Roberts P.A., Rosenthal S.L., Wilkinson C.F. Thyroid-follicular cell carcinogenesis. Fundam. Appl. Toxicol. 12:1989;629-697.
10. Hood A.M., Harstadt E., Klaassen C.D. Effects of UDP-glucuronosyltransferase inducers on thyroid follicular cell proliferation. Toxicologist. 15:1995;229.
11. 1 induces growth inhibition of a human medullary carcinoma cell line despite an increase in steady-state c-myc messenger ribonucleic acid levels. Endocrinology. 135:1994;1887-1893.
12. Kolaja K.L., Johnson J.T., Stevenson D.E., Walborg E.F. Jr., Klaunig J.E. Selective dieldrin promotion of hepatic focal lesions in mice. Carcinogenesis. 17:1996;1243-1250.
13. Koli K., Keski-Oja J. Transforming growth factor-beta system and its regulation by the steroid-thyroid hormone superfamily. Adv. Cancer Res. 70:1996;63-94.
14. Kulkarni A., Karlsson S. Transforming growth factor β1 knockout mice. Am. J. Pathol. 143:1993;3-9.
15. Liu J., Liu Y., Barter R.A., Klaassen C.D. Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study. J. Pharmacol. Exp. Ther. 273:1995;977-985.
16. 1 during thyroid hyperplasia in rats. J. Endocrinol. 141:1994;45-57.
17. 1 in rat thyroid hyperplasia is thyrotropin induced and time dependent. Eur. J. Endocrinol. 134:1996;373-378.
18. Oberhammer F., Bursch W., Tiefenbacher R., Froeschel G., Pavelka M., Purchio T., Schulte-Hermann R. Apoptosis is induced by transforming growth factor-β1 within 5 hours in regressing liver without significant fragmentation of DNA. Hepatology. 18:1993;1238-1246.
19. Okanayu I., Saegusa M., Fujiwara M., Hara Y., Rose N.R. Enhanced cellular proliferative activity and cell death in chronic thyroiditis and thyroid papillary carcinoma. J. Cancer Res. Clin. Oncol. 121:1995;746-752.
20. Oren R., Hilzenrat R., Maaravi Y., Yaari A., Sikuler E. Hemodynamic effects of hypothyroidism induced by methimazole in normal and portal hypertensive rats. Dig. Dis. Sci. 40:1995;1941-1945.
21. Pang X., Park M., Hershman J. Transforming growth factor-β blocks protein kinase-A-mediated iodide transport and protein-kinase-C-mediated DNA synthesis in FRTL-5 rat thyroid cells. Endocrinology. 131:1992;45-50.
22. Pekary A., Berg L., Wang J., Lee P., Dubinett S., Hershmann J. TNF alpha, TSH, and aging regulate TGF-beta synthesis and secretion in FRTL-5 rat thyroid cells. Am. J. Physiol. 268:1995;R808-R815.
23. 1 expression in thyroid gland. Eur. J. Endocrinol. 134:1996;269-271.
24. Sonderfan A.J., Parkinson A. Inhibition of steroid 5(alpha)-reductase and its effects on testosterone hydroxylation by rat liver microsomal cytochrome p-450. Arch. Biochem. Biophys. 265:1988;208-218.
25. Sporn M.B., Roberts A.B. Autocrine growth factors and cancer. Nature. 313:1985;745-747.